Company profile: Vivasure Medical
1.1 - Company Overview
Company description
- Provider of sutureless, fully absorbable vascular closure devices for large-bore vessel punctures in procedures such as TAVR, TEVAR, and EVAR. Products include the PerQseal Closure Device, a synthetic implant, and PerQseal+, an enhanced version with an improved bioabsorbable patch to manage more complex patient anatomies.
Products and services
- PerQseal+ Device: An enhanced, bioabsorbable device that features an improved patch to manage more complex patient anatomies during vascular access closure, building on PerQseal’s sutureless implant design
- PerQseal Closure Device: A sutureless, fully absorbable synthetic implant engineered to seal large-bore vessel punctures in vascular access procedures such as TAVR, TEVAR, and EVAR
- Vascular Access Closure Device Development: Company architects large-bore development of a closure device for vascular access procedures, focusing on sutureless, fully absorbable synthetic implants applicable to TAVR, TEVAR, and EVAR
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Vivasure Medical
Interrad Medical
HQ: United States
Website
- Description: Provider of innovative medical devices for minimally invasive interventional and surgical procedures, including SecurAcath, a subcutaneous anchoring device that secures peripherally inserted central catheters (PICCs) and other central venous catheters (CVCs), reducing the risk of catheter migration and dislodgement.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Interrad Medical company profile →
PLC Medical Systems
HQ: United States
Website
- Description: Provider of health care solutions as a Health Care company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PLC Medical Systems company profile →
Longeveron
HQ: United States
Website
- Description: Provider of cellular therapies and research programs, developing Lomecel-B, a culture-expanded medicinal signaling cell (MSC) therapy for aging-related diseases, Alzheimer’s disease, and hypoplastic left heart syndrome (HLHS), with programs testing its use in aging frailty, metabolic syndrome, and acute respiratory distress syndrome (ARDS) due to COVID-19 or influenza.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Longeveron company profile →
Rapidscan Pharma
HQ: United States
Website
- Description: Provider of regadenoson, a pharmacological stress agent used in the diagnosis and risk stratification of cardiovascular disease, with licensed rights to sell in Europe and select territories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rapidscan Pharma company profile →
Marea Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology therapies leveraging human genetics to develop next-generation treatments for cardiometabolic diseases. Pipeline includes MAR001, a monoclonal antibody targeting ANGPTL4 to reduce remnant cholesterol and triglycerides and improve adipose tissue function (Phase 2), MAR002, an anti-growth hormone receptor antibody for acromegaly, and undisclosed discovery programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Marea Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Vivasure Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vivasure Medical
2.2 - Growth funds investing in similar companies to Vivasure Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Vivasure Medical
4.2 - Public trading comparable groups for Vivasure Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →